Last reviewed · How we verify

NCT06825533: TUN-PREDIAB

The Prevalence of Prediabetes in Primary Care Medicine in Tunisia

Not yet recruiting Last updated 25 February 2025
What this trial tests

trial testing Fasting blood sugar level in Prediabetes in 5,000 participants. Not yet recruiting.

Timeline
21 April 2025
Primary endpoint
21 August 2025
21 August 2025

Quick facts

Lead sponsorDacima Consulting
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment5,000
Start date21 April 2025
Primary completion21 August 2025
Estimated completion21 August 2025

Drugs / interventions tested

Conditions studied

Sponsor

Dacima Consulting

Who can join

18 and older, any sex, with Prediabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is national, observational and cross-sectional and aims to estimate the prevalence of prediabetes in primary care in Tunisia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prediabetes

Currently open trials in the same condition.

Other Dacima Consulting trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06825533.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing